Abstract 448P
Background
Use of chemotherapeutic drugs in advanced age geriatric cancer patients is associated with increased treatment related morbidity, one major neurological complication being peripheral neuropathy is one of major disabling morbidity expected in geriatric population due to poor nutrition status and significant co-morbidities. Our study aims to assess the incidence and severity of chemotherapy induced peripheral neuropathy in geriatric patients with help of CIPN tools when compared to younger patients on chemotherapy.
Methods
A prospective observational study was conducted in medical oncology wards of tertiary care hospital, Bangalore. Subjects with histological confirmed malignancies who had received planned chemotherapy were recruited in this study. All patients underwent a detailed clinical evaluation for screening CIPN at 3rd cycle of chemotherapy, 6th cycle, follow up to 3 months after cessation by using activity daily living screening tool (eviQ tool) , to assess the incidence and severity of symptoms of peripheral neuropathy with objective gradation according to CTCAE V 4.3. Subjects in the study were divided into two groups to those younger than 60 years (group I, n = 63) and those elder or equal to 60 years (group II, n = 32). The incidence and severity of chemotherapy induced peripheral neuropathy in two groups were assessed by screening tools and clinical evaluation.
Results
The incidence of CIPN was more in group II (16/32,IR=50%), (p = 0.282) than group 1 (26/63,IR=44.4%), (p= -0.053). Similarly, according to the CTCAE V4.3 grading, the severity of CIPN was more in group II (p = 0.400) than group I (p = -0.145). The between age groups comparison revealed that there is significant association between increased incidence and severity of CIPN in geriatric patients.
Conclusions
Geriatric patients have greater risk for developing chemotherapy induced peripheral neuropathy (CIPN) when compared to younger use. Adequate use of supportive care would make the reduction in adverse effects, reduce treatment failures, thus allows adequate dosing of drugs and will improve quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
97P - The role of adjuvant chemotherapy according to the status of surgical margin in rectal cancer
Presenter: Jong Hoon Lee
Session: Poster display session
Resources:
Abstract
98P - Influence of DPYD*9, DPYD*6 and GSTP1 ile105val genetic polymorphisms on capecitabine and oxaliplatin (CAPOX) associated toxicities in colorectal cancer patients
Presenter: Ashok Varma
Session: Poster display session
Resources:
Abstract
99P - Patient-derived tumour model by new culture method leading to the precision medicine
Presenter: Norikatsu Miyoshi
Session: Poster display session
Resources:
Abstract
100P - Clinical impact and carcinogenic mechanism of NCAPG overexpression in colon cancer
Presenter: Kai-Yuan Lin
Session: Poster display session
Resources:
Abstract
101P - Combined cellular immunotherapy and chemotherapy improves clinical outcome and displays safety in the treatment of patients with colorectal cancer
Presenter: Chang Wang
Session: Poster display session
Resources:
Abstract
102P - Clinical features of anorectal cancer in patients with Crohn’s disease: Japanese single center study
Presenter: Kazuhiro Watanabe
Session: Poster display session
Resources:
Abstract
103P - Contrast-enhanced CT-based textural parameters as potential prognostic factors of survival for colorectal cancer patients receiving targeted therapy
Presenter: Yanfei Yang
Session: Poster display session
Resources:
Abstract
104P - Prognostic significance of tumour location to the oncologic outcome of colon cancer
Presenter: Sare Hosseini
Session: Poster display session
Resources:
Abstract
105P - Detection and clinical significance of circulating tumour cells in patients with rectal cancer
Presenter: Shuohui Dong
Session: Poster display session
Resources:
Abstract
106P - The risk of malignization incidence in patients with polyps and polyposis of the colon and rectum
Presenter: Yakov Ten
Session: Poster display session
Resources:
Abstract